Csenge Advisory Group’s Medicines Co MDCO Stock Holding History

Csenge Advisory Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20	Closed	–	–	1757
2018 Q3	$0	Buy	+20	New	+$754	﹤0.01%	1831

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Csenge Advisory Group's MDCO Position: Q4 2018 in Review

Csenge Advisory Group sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 20 shares.

Csenge Advisory Group first reported a position in MDCO in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

Csenge Advisory Group reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 20 Medicines Co shares in Q4 2018.
Csenge Advisory Group first reported a position in Medicines Co in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Medicines Co position peaked at $0 in Q3 2018.
188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.